| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2972383 | The Journal of Heart and Lung Transplantation | 2008 | 6 Pages |
Abstract
In heart and lung transplant recipients with invasive aspergillosis, caspofungin seemed to be an effective anti-fungal agent with a promising safety profile. Further prospective randomized trials are needed to investigate an advantageous role of caspofungin in the treatment of invasive aspergillosis.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jan MD, Ingo MD, Thorsten MD, Justus MD, Bruno MD, Thorsten MD, Sabine MD, Bruno MD,